# Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

> **NCT04884308** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 30 (actual)

## Conditions studied

- Cystic Fibrosis
- Bronchiectasis Adult
- Non-Tuberculous Mycobacteria

## Interventions

- **BIOLOGICAL:** BCG TICE Vaccine

## Key facts

- **NCT ID:** NCT04884308
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-28
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04884308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04884308, "Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04884308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*